Clinical Gastroenterology and Hepatology
Volume 10, Issue 1 , Pages 46-51 , January 2012

Adverse Events Do Not Outweigh Benefits of Combination Therapy for Crohn's Disease in a Decision Analytic Model

  • Corey A. Siegel

      Affiliations

    • Dartmouth-Hitchcock Inflammatory Bowel Disease Center, Lebanon, New Hampshire
    • Dartmouth Institute for Health Policy and Clinical Practice, Hanover, New Hampshire
    • Corresponding Author InformationReprint requests Address requests for reprints to: Corey A. Siegel, MD, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756. fax: (603) 650-5225
  • ,
  • Samuel R.G. Finlayson

      Affiliations

    • Dartmouth Institute for Health Policy and Clinical Practice, Hanover, New Hampshire
  • ,
  • Bruce E. Sands

      Affiliations

    • Dr. Henry D. Janowitz Division of Gastroenterology, Mount Sinai School of Medicine, New York, New York
  • ,
  • Anna N.A. Tosteson

      Affiliations

    • Dartmouth Institute for Health Policy and Clinical Practice, Hanover, New Hampshire

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflicts of interest These authors disclose the following: Dr Siegel serves as a consultant to Abbott Laboratories, UCB, and Elan and has delivered CME talks for Merck and Abbott Laboratories. Dr Sands serves as a consultant to Abbott Laboratories, Centocor, and UCB. The remaining authors disclose no conflicts.

 Funding Dr Siegel is supported by a CCFA career development award and by grant number K23DK078678 from the National Institute of Diabetes and Digestive and Kidney Diseases.

PII: S1542-3565(11)01021-4

doi: 10.1016/j.cgh.2011.09.017

Clinical Gastroenterology and Hepatology
Volume 10, Issue 1 , Pages 46-51 , January 2012